Johnson & Johnson to use Baltimore plant for making COVID-19 vaccines
Category: #healthcare  By Mateen Dalal  Date: 2021-04-05
  • share
  • Twitter
  • Facebook
  • LinkedIn

Johnson & Johnson to use Baltimore plant for making COVID-19 vaccines
  • Johnson & Johnson is now left in charge of strictly monitoring the production of the COVID-19 vaccine at the Baltimore plant.
  • The debacle did not affect any vaccines that are presently being used or delivered.

Johnson & Johnson has been reportedly put in charge of a Baltimore vaccine manufacturing plant that destroyed 15 million doses of the firm’s COVID-19 vaccine. The United States has barred British drug maker AstraZeneca Plc from using the facility to avoid any future errors.

Emergent Biosolutions, a Baltimore-based facility, had previously been selected as a manufacturing partner by both Johnson & Johnson and AstraZeneca. Johnson & Johnson said that it was taking full responsibility for the production of drug substances for its coronavirus vaccine at Emergent BioSolutions.

The recent turn of events is likely to harm AstraZeneca which is yet to obtain COVID-19 vaccine approval in the United States.

The move comes after it was revealed that Emergent, which manufactures vaccines for both AstraZeneca and Johnson & Johnson, mixed up ingredients from two COVID-19 vaccines due to human error, prompting regulators to postpone the facility's vaccine production authorization, cited sources knowledgeable with the matter.

According to Johnson and Johnson, the quality management process at Emergent Biosolutions, a site not yet authorized to produce drug substances for their COVID-19 vaccine, found one batch of drug substance that did not meet quality requirements.

Following the blunder, the company stated it is recruiting dedicated leaders for operations and quality control, as well as expanding the number of production capabilities, and increasing quality and technical operations staff to work with existing specialists Emergent.

Johnson and Johnson mentioned that all their coronavirus vaccine doses distributed to date have met stringent regulatory quality requirements.

Source Credit –

https://www.businessinsider.in/international/news/us-halts-astrazeneca-covid-19-vaccine-production-at-baltimore-plant-where-15-million-jj-vaccines-were-ruined/articleshow/81897534.cms

 

About Author

Mateen Dalal    

Mateen Dalal

Despite working as a professional testing engineer, Mateen Dalal always held a liking for content creation. Following his passion, he now pens down articles for itresearchbrief.com and a couple of similar portals. Mateen is a qualified electronics and telecommunicat...

Read More>>

More News By Mateen Dalal

French lawmakers approve a bill to deal with fourth wave of Coronavirus
French lawmakers approve a bill to deal with fourth wave of Coronavirus
By Mateen Dalal

The French parliament recently approved a bill that makes Covid-19 vaccination mandatory for health ...

China scraps WHO’s plans for 2nd phase of Covid-19 origin study
China scraps WHO’s plans for 2nd phase of Covid-19 origin study
By Mateen Dalal

The World Health Organization’s plan for a deeper probe into the origin of the coronavirus was...

U.S. opioid lawsuits nears USD 26 Bn settlement with pharma giants
U.S. opioid lawsuits nears USD 26 Bn settlement with pharma giants
By Mateen Dalal

US state attorneys general recently announced being on the verge of a USD 26 billion settlement with...